LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Myocardial injury determination improves risk stratification and predicts mortality in COVID-19 patients.

    Lorente-Ros, Alvaro / Monteagudo Ruiz, Juan Manuel / Rincón, Luis M / Ortega Pérez, Rodrigo / Rivas, Sonia / Martínez-Moya, Rafael / Sanromán, Maria Ascensión / Manzano, Luis / Alonso, Gonzalo Luis / Ibáñez, Borja / Zamorano, Jose Luis

    Cardiology journal

    2020  Volume 27, Issue 5, Page(s) 489–496

    Abstract: ... of myocardial injury assessment on risk stratification of COVID-19 patients.: Methods: Seven hundred seven ... regression models significantly improves their performance in predicting mortality. The determination ... in three risk groups (high, intermediate and low) with a clearly distinct 30-day mortality. ...

    Abstract Background: Despite being associated with worse prognosis in patients with COVID-19, systematic determination of myocardial injury is not recommended. The aim of the study was to study the effect of myocardial injury assessment on risk stratification of COVID-19 patients.
    Methods: Seven hundred seven consecutive adult patients admitted to a large tertiary hospital with confirmed COVID-19 were included. Demographic data, comorbidities, laboratory results and clinical outcomes were recorded. Charlson comorbidity index (CCI) was calculated in order to quantify the degree of comorbidities. Independent association of cardiac troponin I (cTnI) increase with outcomes was evaluated by multivariate regression analyses and area under curve. In addition, propensity-score matching was performed to assemble a cohort of patients with similar baseline characteristics.
    Results: In the matched cohort (mean age 66.76 ± 15.7 years, 37.3% females), cTnI increase above the upper limit was present in 20.9% of the population and was associated with worse clinical outcomes, including all-cause mortality within 30 days (45.1% vs. 23.2%; p = 0.005). The addition of cTnI to a multivariate prediction model showed a significant improvement in the area under the time-dependent receiver operating characteristic curve (0.775 vs. 0.756, DC-statistic = 0.019; 95% confidence interval 0.001-0.037). Use of renin-angiotensin-aldosterone system inhibitors was not associated with mortality after adjusting by baseline risk factors.
    Conclusions: Myocardial injury is independently associated with adverse outcomes irrespective of baseline comorbidities and its addition to multivariate regression models significantly improves their performance in predicting mortality. The determination of myocardial injury biomarkers on hospital admission and its combination with CCI can classify patients in three risk groups (high, intermediate and low) with a clearly distinct 30-day mortality.
    MeSH term(s) Aged ; Betacoronavirus ; COVID-19 ; Cardiomyopathies/diagnosis ; Cardiomyopathies/mortality ; Cardiomyopathies/virology ; Coronavirus Infections/complications ; Coronavirus Infections/mortality ; Coronavirus Infections/therapy ; Critical Care ; Female ; Humans ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/mortality ; Pneumonia, Viral/therapy ; Predictive Value of Tests ; ROC Curve ; Retrospective Studies ; Risk Factors ; SARS-CoV-2 ; Survival Rate ; Troponin I/blood
    Chemical Substances Troponin I
    Keywords covid19
    Language English
    Publishing date 2020-06-26
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 2488680-4
    ISSN 1898-018X ; 1897-5593
    ISSN (online) 1898-018X
    ISSN 1897-5593
    DOI 10.5603/CJ.a2020.0089
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Book ; Online: Myocardial injury determination improves risk stratification and predicts mortality in COVID-19 patients

    Lorente-Ros, Alvaro / Monteagudo Ruiz, Juan Manuel / Rincón, Luis M. / Ortega Pérez, Rodrigo / Rivas, Sonia / Martínez-Moya, Rafael / Sanromán, Maria Ascensión / Manzano, Luis / Alonso, Gonzalo Luis / Ibáñez, Borja / Zamorano, Jose Luis

    Cardiology Journal; Vol 27, No; 489-496

    2020  Volume 5

    Abstract: ... of myocardial injury assessment on risk stratification of COVID-19 patients.Methods: Seven hundred seven ... regression models significantly improves their performance in predicting mortality. The determination ... in three risk groups (high, intermediate and low) with a clearly distinct 30-day mortality. ...

    Abstract Background: Despite being associated with worse prognosis in patients with COVID-19, systematic determination of myocardial injury is not recommended. The aim of the study was to study the effect of myocardial injury assessment on risk stratification of COVID-19 patients.Methods: Seven hundred seven consecutive adult patients admitted to a large tertiary hospital with confirmed COVID-19 were included. Demographic data, comorbidities, laboratory results and clinical outcomes were recorded. Charlson comorbidity index (CCI) was calculated in order to quantify the degree of comorbidities. Independent association of cardiac troponin I (cTnI) increase with outcomes was evaluated by multivariate regression analyses and area under curve. In addition, propensity-score matching was performed to assemble a cohort of patients with similar baseline characteristics.Results: In the matched cohort (mean age 66.76 ± 15.7 years, 37.3% females), cTnI increase above the upper limit was present in 20.9% of the population and was associated with worse clinical outcomes, including all-cause mortality within 30 days (45.1% vs. 23.2%; p = 0.005). The addition of cTnI to a multivariate prediction model showed a significant improvement in the area under the time-dependent receiver operating characteristic curve (0.775 vs. 0.756, DC-statistic = 0.019; 95% confidence interval 0.001–0.037). Use of renin–angiotensin–aldosterone system inhibitors was not associated with mortality after adjusting by baseline risk factors.Conclusions: Myocardial injury is independently associated with adverse outcomes irrespective of baseline comorbidities and its addition to multivariate regression models significantly improves their performance in predicting mortality. The determination of myocardial injury biomarkers on hospital admission and its combination with CCI can classify patients in three risk groups (high, intermediate and low) with a clearly distinct 30-day mortality.
    Keywords cardiac injury ; myocardial injury ; troponin ; coronavirus ; COVID-19 ; cardiovascular disease ; covid19
    Language English
    Publishing date 2020-11-06
    Publisher Via Medica
    Publishing country pl
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article: Myocardial injury determination improves risk stratification and predicts mortality in COVID-19 patients

    Lorente-Ros, Alvaro / Monteagudo Ruiz, Juan Manuel / Rincón, Luis M / Ortega Pérez, Rodrigo / Rivas, Sonia / Martínez-Moya, Rafael / Sanromán, Maria Ascensión / Manzano, Luis / Alonso, Gonzalo Luis / Ibáñez, Borja / Zamorano, Jose Luis

    Cardiol J

    Abstract: ... of myocardial injury assessment on risk stratification of COVID-19 patients. METHODS: Seven hundred seven ... regression models significantly improves their performance in predicting mortality. The determination ... in three risk groups (high, intermediate and low) with a clearly distinct 30-day mortality. ...

    Abstract BACKGROUND: Despite being associated with worse prognosis in patients with COVID-19, systematic determination of myocardial injury is not recommended. The aim of the study was to study the effect of myocardial injury assessment on risk stratification of COVID-19 patients. METHODS: Seven hundred seven consecutive adult patients admitted to a large tertiary hospital with confirmed COVID-19 were included. Demographic data, comorbidities, laboratory results and clinical outcomes were recorded. Charlson comorbidity index (CCI) was calculated in order to quantify the degree of comorbidities. Independent association of cardiac troponin I (cTnI) increase with outcomes was evaluated by multivariate regression analyses and area under curve. In addition, propensity-score matching was performed to assemble a cohort of patients with similar baseline characteristics. RESULTS: In the matched cohort (mean age 66.76 ± 15.7 years, 37.3% females), cTnI increase above the upper limit was present in 20.9% of the population and was associated with worse clinical outcomes, including all-cause mortality within 30 days (45.1% vs. 23.2%; p = 0.005). The addition of cTnI to a multivariate prediction model showed a significant improvement in the area under the time-dependent receiver operating characteristic curve (0.775 vs. 0.756, DC-statistic = 0.019; 95% confidence interval 0.001-0.037). Use of renin-angiotensin-aldosterone system inhibitors was not associated with mortality after adjusting by baseline risk factors. CONCLUSIONS: Myocardial injury is independently associated with adverse outcomes irrespective of baseline comorbidities and its addition to multivariate regression models significantly improves their performance in predicting mortality. The determination of myocardial injury biomarkers on hospital admission and its combination with CCI can classify patients in three risk groups (high, intermediate and low) with a clearly distinct 30-day mortality.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #614995
    Database COVID19

    Kategorien

To top